$32,987,556
Follow-On Offering
Preferred Stock Offering
Co-Manager
$57,546,000
Follow-On Offering
Joint Bookrunning Manager
$58,822,500
Follow-On Offering
Co-Manager
Sale to ACL
$87,942,169
Follow-On Offering
Co-Manager
$291,721,808
Initial Public Offering
Co-Manager
$179,400,000
Follow-On Offering
Co-Manager
$35,035,000
Follow-On Offering
Co-Manager
Sale of Assets to
Eli Lilly and Company
$33,160,923
Follow-On Offering
Lead Manager
$130,085,000
Asset-Backed Notes
Co-Manager
$46,575,000
Follow-On Offering
Co-Manager
$44,000,000
Follow-On Offering
Co-Manager
$102,747,000
Follow-On Offering
Joint Bookrunning Manager
$316,249,997
Follow-On Offering
Co-Manager
$15,850,000
Convertible Senior Notes
Joint Bookrunning Manager
$151,875,000
Initial Public Offering
Co-Manager
$138,000,000
Follow-On Offering
Co-Manager